204 related articles for article (PubMed ID: 10676925)
1. Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: case reports from two University Hospital Medical Centers.
Waintraub SE; Brody JI
Semin Hematol; 2000 Jan; 37(1 Suppl 1):45-9. PubMed ID: 10676925
[TBL] [Abstract][Full Text] [Related]
2. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB
Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261
[TBL] [Abstract][Full Text] [Related]
3. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
George JN; Raskob GE; Vesely SK; Moore D; Lyons RM; Cobos E; Towell BL; Klug P; Guthrie TH
Am J Hematol; 2003 Nov; 74(3):161-9. PubMed ID: 14587042
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
5. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
Blanchette V; Carcao M
Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for chronic idiopathic (immune) thrombocytopenic purpura.
George JN
Semin Hematol; 2000 Jan; 37(1 Suppl 1):31-4. PubMed ID: 10676922
[TBL] [Abstract][Full Text] [Related]
10. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
11. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: the New York Hospital experience.
Scaradavou A
Semin Hematol; 2000 Jan; 37(1 Suppl 1):42-4. PubMed ID: 10676924
[TBL] [Abstract][Full Text] [Related]
14. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
Bussel JB; Kaufmann CP; Ware RE; Woloski BM
Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy.
Griffiths J; Sia W; Shapiro AM; Tataryn I; Turner AR
J Obstet Gynaecol Can; 2005 Aug; 27(8):771-4. PubMed ID: 16287009
[TBL] [Abstract][Full Text] [Related]
16. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
19. Danazol therapy for chronic immune-mediated thrombocytopenic purpura in a patient with common variable immunodeficiency.
Saulsbury FT; Bringelsen KA
Am J Pediatr Hematol Oncol; 1991; 13(3):326-9. PubMed ID: 1793160
[TBL] [Abstract][Full Text] [Related]
20. Management of immune thrombocytopenic purpura in children: potential role of novel agents.
Bredlau AL; Semple JW; Segel GB
Paediatr Drugs; 2011 Aug; 13(4):213-23. PubMed ID: 21692546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
